AS1810722
AS1810722 is an orally active and potent STAT6 inhibitor (IC50 :1.9 nM) . AS1810722 shows a good profile of CYP3A4 inhibition. AS1810722, a derivative of fused bicyclic pyrimidine, has the potential for allergic diseases such as asthma and atopic diseases research.
Product Specifications
CAS Number
909561-15-5
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
477.52
Molecular Formula
C25H25F2N7O
Notes
Research use only, not for human use.
Receptor
CYP3A4|STAT6
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1188515-01 0.02 mg (E-Coli)
Recombinant Yersinia pseudotuberculosis serotype O:3 Sulfurtransferase TusD (tusD)
Sign In for Pricing
View Details MBS1188515-02 0.1 mg (E-Coli)
Recombinant Yersinia pseudotuberculosis serotype O:3 Sulfurtransferase TusD (tusD)
Sign In for Pricing
View Details MBS1188515-03 0.02 mg (Yeast)
Recombinant Yersinia pseudotuberculosis serotype O:3 Sulfurtransferase TusD (tusD)
Sign In for Pricing
View Details MBS1188515-04 0.1 mg (Yeast)
Recombinant Yersinia pseudotuberculosis serotype O:3 Sulfurtransferase TusD (tusD)
Sign In for Pricing
View Details